Interestingly, a risk prediction tool named Pro-FHH including serum Ca2+ levels, PTH, osteocalcin and CCCR has been proposed to better discriminate between FHH and PHPT [23]. This evidence concerns the gene BGLAP and familial hypocalciuric hypercalcemia.